These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7080865)

  • 41. [Letter: Myeloma and myelo-monocytic leukemia. Role of melphalan].
    Marsan C; Henon P; Quillard A; Grimaldi A; Cywiner-Golener C
    Nouv Presse Med; 1973 Dec; 2(44):2958. PubMed ID: 4521337
    [No Abstract]   [Full Text] [Related]  

  • 42. Multiple myeloma--intermittent combination chemotherapy compared to continuous therapy.
    George RP; Poth JL; Gordon D; Schrier SL
    Cancer; 1972 Jun; 29(6):1665-70. PubMed ID: 4113171
    [No Abstract]   [Full Text] [Related]  

  • 43. Leukemia on myeloma.
    Quirt IC; Hart GD; Soots M
    Br Med J; 1972 Jan; 1(5794):248. PubMed ID: 4500986
    [No Abstract]   [Full Text] [Related]  

  • 44. [Erythroleukemia in multiple myeloma. A case report].
    Streuli R; Voellmy W
    Schweiz Med Wochenschr; 1987 Feb; 117(8):286-91. PubMed ID: 3470922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute myeloblastic leukemia in patients with multiple myeloma.
    Maj S; Mendek E; Snigurowicz J; Kraj M; Michalak T; Słomkowski M; Apel D
    Mater Med Pol; 1982; 14(1-2):21-9. PubMed ID: 6964682
    [No Abstract]   [Full Text] [Related]  

  • 46. [Acute myelogenous leukemia in myelomatosis].
    Tidsskr Nor Laegeforen; 1977 Feb; 97(4):175-7. PubMed ID: 265102
    [No Abstract]   [Full Text] [Related]  

  • 47. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
    Kaya H; Nakamura S; Yamazaki H; Kumabashiri I; Ohtake S; Matsuda T
    Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leukaemia and cytotoxic drugs.
    Lancet; 1971 Jan; 1(7689):70-1. PubMed ID: 4099223
    [No Abstract]   [Full Text] [Related]  

  • 49. Repeat administration of high dose melphalan in relapsed myeloma.
    Mansi JL; Cunningham D; Viner C; Ellis E; Meldrum M; Milan S; Gore M
    Br J Cancer; 1993 Nov; 68(5):983-7. PubMed ID: 8217614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alkeran and multiple myeloma.
    Med Lett Drugs Ther; 1966 Apr; 8(8):32. PubMed ID: 5913764
    [No Abstract]   [Full Text] [Related]  

  • 51. Acute leukemia secondary to multiple myeloma.
    de Gramont A; Rioux E; Shields C
    Can Med Assoc J; 1983 Sep; 129(6):534, 536. PubMed ID: 6576845
    [No Abstract]   [Full Text] [Related]  

  • 52. Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.
    Palumbo A; Falco P; Corradini P; Falcone A; Di Raimondo F; Giuliani N; Crippa C; Ciccone G; Omedè P; Ambrosini MT; Gay F; Bringhen S; Musto P; Foà R; Knight R; Zeldis JB; Boccadoro M; Petrucci MT;
    J Clin Oncol; 2007 Oct; 25(28):4459-65. PubMed ID: 17785703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up.
    Berenson JR; Yang HH; Vescio RA; Nassir Y; Mapes R; Lee SP; Wilson J; Yellin O; Morrison B; Hilger J; Swift R
    Ann Hematol; 2008 Aug; 87(8):623-31. PubMed ID: 18463870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Acute leukemia in multiple myeloma: case histories, a review of the literature and assessment of the incidence].
    Bierbach H; Zeile G; Wellek S; Fischer J
    Klin Wochenschr; 1979 Aug; 57(15):769-77. PubMed ID: 385972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unusual cases of myelomatosis.
    Videbaek A
    Br Med J; 1971 May; 2(5757):326. PubMed ID: 4996472
    [No Abstract]   [Full Text] [Related]  

  • 56. [Acute leukemia in a case of multiple myeloma].
    van Hove W; Hamers J
    Ned Tijdschr Geneeskd; 1973 Sep; 117(39):1462-5. PubMed ID: 4522766
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model.
    Grazziutti ML; Dong L; Miceli MH; Krishna SG; Kiwan E; Syed N; Fassas A; van Rhee F; Klaus H; Barlogie B; Anaissie EJ
    Bone Marrow Transplant; 2006 Oct; 38(7):501-6. PubMed ID: 16980998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral complications of high-dose melphalan in multiple myeloma.
    Barrett AP; Buckley DJ
    Oral Surg Oral Med Oral Pathol; 1987 Aug; 64(2):264-7. PubMed ID: 3476906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma.
    McElwain TJ; Powles RL
    Lancet; 1983 Oct; 2(8354):822-4. PubMed ID: 6137651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solid tumors in multiple myeloma.
    Stegman R; Alexanian R
    Ann Intern Med; 1979 May; 90(5):780-2. PubMed ID: 434680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.